Placebo (inhalation powder capsules) containing 1 of 4 dosage strengths of TPIP (80 μg, 160 μg, or 320 μg or 640 µg ), TREPROSTINIL PALMITIL INHALATION POWDER, TREPROSTINIL PALMITIL INHALATION POWDER, TREPROSTINIL PALMITIL INHALATION POWDER, TREPROSTINIL PALMITIL INHALATION POWDER
INS1009-311
Phase 3 small_molecule active
Quick answer
Placebo (inhalation powder capsules) containing 1 of 4 dosage strengths of TPIP (80 μg, 160 μg, or 320 μg or 640 µg ), TREPROSTINIL PALMITIL INHALATION POWDER, TREPROSTINIL PALMITIL INHALATION POWDER, TREPROSTINIL PALMITIL INHALATION POWDER, TREPROSTINIL PALMITIL INHALATION POWDER for Pulmonary Hypertension Associated with Interstitial Lung Disease is a Phase 3 program (small_molecule) at Insmed Limited with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Insmed Limited
- Indication
- Pulmonary Hypertension Associated with Interstitial Lung Disease
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active